09966.HK
Alphamab Oncology
HKSE · Healthcare · Biotechnology · CN
HKD 6.49
−0.92%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 18.18x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.17x
- Price / sales
- 10.30x
- Price / cash flow
- -33.97x
Enterprise value
- Enterprise value
- HKD 4.9B
- EV / sales
- 8.04x
- EV / EBITDA
- -31.62x
- EV / EBIT
- -21.13x
- Market cap
- HKD 6.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026